← Leaderboards
Stephen Boorjian
Sloan-Kettering Inst Can Research
$370,818
Attributed
$1,854,090
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $472.8K · FY2012–15$500K$375K$250K$125K$0
'12
'13
'14
'15
Funding mix
By agency
NIH$1,854,090 · 1
By mechanism
R01$1,854,090 · 1
Top collaborators
- Matthew R Cooperberg4 shared
- Richard Bernard Hayes4 shared
- Hans GãSta Lilja4 shared
- Andrew J Vickers4 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Brett Stewart Carver$12,016,524
- Hans Gãsta Lilja$2,754,869
- Matthew R Cooperberg$4,615,223
- Jeanne Ruperto$4,583,791
- Michelle S Bradbury$7,087,200
Others in their field
Top investigators on “Validation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$515,091,456
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- David Heimbrook · Leidos Biomedical Research, Inc.$239,311,963
Research focus
ValidationArchivesArea Under CurveBaseBiopsyBloodBlood SpecimenCancer DetectionClinical Decision-MakingClinical PracticeCohortDecision AnalysisDiagnostic Neoplasm StagingDry IceEuropeEuropeanFreezingKininogenaseLaboratoriesLaboratory ResearchLimited StageMalignant Neoplasm Of ProstateMalignant NeoplasmsMeasurement
Grant awards (4)
Prospective validation of a multi-marker prostate cancer prediction model$464,784
R01 · FY2015 · CA
Prospective validation of a multi-marker prostate cancer prediction model$452,928
R01 · FY2014 · CA
Prospective validation of a multi-marker prostate cancer prediction model$463,618
R01 · FY2013 · CA
Prospective validation of a multi-marker prostate cancer prediction model$472,760
R01 · FY2012 · CA